1. USP39, a direct target of microRNA-133a, promotes progression of pancreatic cancer via the AKT pathway
    Jing Cai et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  2. The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay
    Maghawry Hegazy et al, 2023, Pathology - Research and Practice CrossRef
  3. Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem
    Michela Falco et al, 2022, Cancers CrossRef
  4. Facilitating the Cellular Accumulation of Pt-Based Chemotherapeutic Drugs
    Ian Lambert et al, 2018, International Journal of Molecular Sciences CrossRef
  5. Non-coding RNAs in drug resistance of head and neck cancers: A review
    Fengsheng Dai et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  6. MiR-133a-3p overexpression-induced elevation of cisplatin-mediated chemosensitivity to non-small cell lung cancer by targeting replication factor C3
    Guanqun Dai et al, 2021, Process Biochemistry CrossRef
  7. miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses
    Hesham A. El-Mahdy et al, 2023, Pathology - Research and Practice CrossRef
  8. miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy
    Yang Zhou et al, 2022, Cancer Cell International CrossRef
  9. LncRNA SNHG14 regulates the DDP-resistance of non-small cell lung cancer cell through miR-133a/HOXB13 pathway
    Li Xu et al, 2020, BMC Pulmonary Medicine CrossRef
  10. Astragalus Polysaccharide Suppresses Cell Proliferation and Invasion by Up-Regulation of miR-195-5p in Non-small Cell Lung Cancer
    Xingkui Tao et al, 2022, Biological and Pharmaceutical Bulletin CrossRef
  11. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
    Jiabei Zhou et al, 2020, Frontiers in Pharmacology CrossRef
  12. MiR‐133a‐3p attenuates resistance of non‐small cell lung cancer cells to gefitinib by targeting SPAG5
    Qing Li et al, 2021, Journal of Clinical Laboratory Analysis CrossRef
  13. Peculiarities of interaction of malignant cells and tumors with chemotherapeutic nanocomposite remedies
    null null et al, 2023, Surface CrossRef